How can clinicians better tailor cardiac surveillance for patients receiving HER2-targeted therapy? Join the virtual JACC: CardioOncology Journal Club on Wednesday, Nov. 18 at 10:30 a.m. ET as a panel of experts examine emerging evidence on cardiovascular risk stratification and monitoring – and discuss opportunities for a more individualized approach to cardiovascular care during cancer treatment. Gain clinically relevant insights that can help inform decisions about which patients warrant closer monitoring and which may safely undergo less intensive surveillance. Reserve your spot today to earn 1 CME credit.